Biomm SA (BIOM3) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Biomm SA Company Snapshot

Business Description:

Biomm SA operates in the Commercial physical research sector. Biomm SA is a Brazil-based company active in the biotechnology industry. It is principally engaged in the development of technology for the production of human insulin and other recombinant proteins. Its technology is suitable for the production of therapeutic proteins such as calcitonin, interferons and growth hormones. In addition, the Company is active in biotechnological processes for industrial purposes, such as enzymes used in the production of biofuels. Biomm SA's technology for insulin production is patented in Brazil and in countries in Europe, North America and Asia. As of December 31, 2009, the Company's major shareholder was Bio Participacoes Consultoria Tecnica. In our complete report available for purchase the company is compared to: Telesso Technologies Ltd, Bioheart, Incorporation and Phylogica Limited.

Biomm SA

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 2.15
(Figures in Brazilian Reals)

1 Week	34.4%	13 Weeks	8.0%

4 Weeks	19.4%	52 Weeks	n/a

Biomm SA Key Data:

Ticker:	BIOM3	Country:	BRAZIL

Exchanges:	SOP	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	877,000 (Year Ending Jan 2011).	Employees:	N/A

Currency:	Brazilian Reals	Market Cap:	37,278,491

Fiscal Yr Ends:	December	Shares Outstanding:	17,338,833

Share Type:	Ordinaria	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.